![Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company's headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd Wiegmann Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company's headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd Wiegmann](https://c8.alamy.com/comp/2CJY5EY/jean-paul-clozel-ceo-of-swiss-pharmaceutical-company-idorsia-attends-an-interview-with-reuters-at-the-companys-headquarters-in-allschwil-near-basel-switzerland-may-15-2018-picture-taken-may-15-2018-reutersarnd-wiegmann-2CJY5EY.jpg)
Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company's headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd Wiegmann
![Jean-Paul Girardin, CEO of independent watchmaker Breitling gestures during an interview in the company headquarters in La Chaux-de-Fonds, Switzerland, May 26, 2016. REUTERS/Denis Balibouse Stock Photo - Alamy Jean-Paul Girardin, CEO of independent watchmaker Breitling gestures during an interview in the company headquarters in La Chaux-de-Fonds, Switzerland, May 26, 2016. REUTERS/Denis Balibouse Stock Photo - Alamy](https://c8.alamy.com/comp/2E6MDD3/jean-paul-girardin-ceo-of-independent-watchmaker-breitling-gestures-during-an-interview-in-the-company-headquarters-in-la-chaux-de-fonds-switzerland-may-26-2016-reutersdenis-balibouse-2E6MDD3.jpg)
Jean-Paul Girardin, CEO of independent watchmaker Breitling gestures during an interview in the company headquarters in La Chaux-de-Fonds, Switzerland, May 26, 2016. REUTERS/Denis Balibouse Stock Photo - Alamy
![Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann ( SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann ( SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy](https://l450v.alamy.com/450v/2d0n01x/swiss-biotech-group-actelion-ceo-jean-paul-clozel-arrives-for-his-companys-annual-general-meeting-in-basel-may-5-2011-reuterschristian-hartmann-switzerland-tags-business-health-2d0n01x.jpg)
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann ( SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
![Jean-Paul PFLIEGER - Sales Manager France, Spain, Italy & Switzerland - Jaquet Technology Group | XING Jean-Paul PFLIEGER - Sales Manager France, Spain, Italy & Switzerland - Jaquet Technology Group | XING](https://profile-images.xing.com/images/0a14f37260d2ce93cf7c1e3908ff8b30-4/jean-paul-pflieger.256x256.jpg)